View Older Stories

Feb 17, 2026 10:40AM Disc Medicine (IRON) PT Lowered to $110 at Stifel Following FDA CRL for Bitopertin

Feb 17, 2026 10:10AM Disc Medicine (IRON) PT Lowered to $125 at Cantor Fitzgerald, Overweight Rating Maintained

Feb 13, 2026 03:05PM FDA issues Complete Response Letter for Disc Medicine's bitopertin EPP treatment

Jan 29, 2026 04:49AM BMO Capital Reiterates Outperform Rating on Disc Medicine (IRON)

Jan 15, 2026 12:00PM Morgan Stanley says 'buy the dip' in Disc Medicine (IRON)

Jan 15, 2026 10:38AM Stifel on Disc Medicine (IRON): 'More Speculative Regulatory Chatter Emerges – We’re Still Bullish on Risk/Reward Here'

Jan 15, 2026 06:02AM FDA delays reviews of Sanofi's Tzield and Disc Medicine's bitopertin

Jan 12, 2026 04:30PM Disc Medicine hires Lisa Amaya Price as chief human resources officer

Jan 12, 2026 08:33AM Disc Medicine receives FDA priority review voucher for bitopertin

Dec 19, 2025 04:08PM Stifel on Disc Medicine (IRON): 'favor owning the stock on the basis of IRON’s programs in myelofibrosis and polycythemia vera'

Dec 19, 2025 03:26PM Jefferies Defends Disc Medicine (IRON): 'Overreaction to Article on IRON EPP Approvability Under CNPV'

Dec 19, 2025 02:14PM BMO on Disc Medicine (IRON) Post Mgmt Call: 'management indicated that FDA has given no indication that the NDA review process is currently at risk'

Dec 9, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)

Dec 8, 2025 08:20AM Disc Medicine (IRON) PT Raised to $117 at Raymond James

Dec 8, 2025 04:16AM Disc Medicine (IRON) PT Raised to $115 at Leerink Partners

Nov 20, 2025 04:10AM Jefferies Reiterates Buy Rating on Disc Medicine (IRON)

Nov 3, 2025 06:49AM Stifel Resumes Disc Medicine (IRON) at Buy

Oct 31, 2025 10:47AM Raymond James on Disc Medicine (IRON): 'we believe DISC-0974 peak sales could approach ~$1B+ in MF alone'

Oct 20, 2025 06:30AM Disc Medicine submits drug application, receives priority review voucher

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 17, 2025 08:21AM Truist on Disc Medicine (IRON): 'A Bullish Indicator If We Ever Saw One'

Oct 17, 2025 06:59AM Disc Medicine (IRON) PT Raised to $153 at Cantor Fitzgerald After FDA Priority Voucher Win

Oct 17, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)

Oct 17, 2025 05:17AM Disc Medicine (IRON) PT Raised to $108 at Raymond James

Oct 17, 2025 05:14AM Disc Medicine (IRON) PT Raised to $100 at Leerink Partners, 'one of our Top Picks for 2025'

Oct 16, 2025 05:36PM Disc Medicine receives FDA priority voucher for EPP drug bitopertin

Sep 30, 2025 08:34AM Disc Medicine submits FDA application for rare blood disorder drug

Aug 20, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Disc Medicine (IRON)

Aug 7, 2025 09:37AM Disc Medicine (IRON) Misses Q2 EPS by 46c

Jul 21, 2025 08:04AM Disc Medicine plans to submit bitopertin NDA in October 2025

Jul 21, 2025 07:31AM Truist Securities Starts Disc Medicine (IRON) at Buy

Jul 18, 2025 09:44AM Raymond James Reiterates Strong Buy Rating on Disc Medicine (IRON)

Jul 14, 2025 08:30AM Disc Medicine adds Cullinan Therapeutics CEO to board

Jul 3, 2025 07:30AM Morgan Stanley Assumes Disc Medicine (IRON) at Overweight

Jul 3, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)

Jun 17, 2025 10:04AM BMO Capital Reiterates Outperform Rating on Disc Medicine (IRON)

Jun 17, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)

Jun 12, 2025 07:30AM Disc Medicine (IRON) Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association

May 7, 2025 04:23PM Disc Medicine (IRON) Tops Q1 EPS by 12c

Mar 5, 2025 08:34AM Cantor Fitzgerald Reiterates Overweight Rating on Disc Medicine (IRON)

Mar 3, 2025 06:55AM Disc Medicine (IRON) PT Raised to $75 at Scotiabank

Feb 27, 2025 05:41AM TD Cowen Starts Disc Medicine (IRON) at Buy

Jan 24, 2025 10:14AM Disc Medicine (IRON) PT Raised to $94 at Stifel

Jan 21, 2025 04:04PM Disc Medicine (IRON) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Jan 21, 2025 07:46AM Disc Medicine (IRON) Announces Successful Type C Meeting with FDA for Bitopertin

Jan 2, 2025 04:00PM Biotech outlook for 2025: Stifel

Jan 2, 2025 10:56AM Stifel Highlights Iovanace Biotherapeutics (IOVA) as 'Top Pick' in Biotech's 2025 Outlook Note

Dec 9, 2024 12:03PM Disc Medicine (IRON) Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology

Nov 27, 2024 02:28PM Jefferies Reiterates Buy Rating on Disc Medicine (IRON)

Nov 13, 2024 06:53AM Disc Medicine (IRON) PT Raised to $118 at H.C. Wainwright

View Older Stories